(Q42947318)

11 November 2017

title

Efficacy of akatinol memantine in moderate cognitive impairments (English)

1 reference

11 November 2017

main subject

cognitive dysfunction

1 reference

O S Levin

1

1 reference

11 November 2017

N A Yunishchenko

series ordinal

2

1 reference

11 November 2017

M A Dudarova

series ordinal

3

1 reference

11 November 2017

publication date

1 October 2010

1 reference

Neuroscience and Behavioral Physiology

11 November 2017

published in

1 reference

11 November 2017

volume

40

1 reference

11 November 2017

issue

8

1 reference

11 November 2017

page(s)

926-933

1 reference

An Inventory for Measuring Depression

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11055-010-9347-8

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11055-010-9347-8

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11055-010-9347-8

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11055-010-9347-8

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11055-010-9347-8

Reliability, validity, and clinical correlates of apathy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11055-010-9347-8

Clinical trials in mild cognitive impairment: lessons for the future

21 January 2018

1 reference

12 December 2020

Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature

1 reference

12 December 2020

Diagnosis and treatment of moderate cognitive disorders in the elderly

1 reference

12 December 2020

Predictors of progression from mild cognitive impairment to Alzheimer disease.

1 reference

12 December 2020

Ginkgo biloba for prevention of dementia: a randomized controlled trial

1 reference

12 December 2020

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

12 December 2020

The ten point clock test: a quick screen and grading method for cognitive impairment in medical and surgical patients

1 reference

12 December 2020

Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.

1 reference

12 December 2020

Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis

1 reference

12 December 2020

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

12 December 2020

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies

1 reference

12 December 2020

Mild cognitive impairment: clinical characterization and outcome

1 reference

12 December 2020

Current concepts in mild cognitive impairment

1 reference

12 December 2020

1 reference

12 December 2020

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

12 December 2020

Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.

1 reference

12 December 2020

Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat--a pharmacokinetic microdialysis study

1 reference

12 December 2020

Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease.

1 reference

12 December 2020

Memantine in moderate-to-severe Alzheimer's disease

1 reference

12 December 2020

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

1 reference

12 December 2020

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease

1 reference

12 December 2020

Safety and efficacy of galantamine in subjects with mild cognitive impairment

1 reference

12 December 2020

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

12 December 2020

Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300).

1 reference

12 December 2020

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

12 December 2020

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study

1 reference

12 December 2020

Executive cognitive impairment: a novel perspective on dementia

1 reference

12 December 2020

Predicting rapid clinical progression in amnestic mild cognitive impairment

1 reference

12 December 2020

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

12 December 2020

The SKT--a short cognitive performance test for assessing deficits of memory and attention.

1 reference

12 December 2020

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

1 reference

12 December 2020

Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration

1 reference

12 December 2020

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

12 December 2020

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials

1 reference

12 December 2020

Memantine agonist action at dopamine D2High receptors

1 reference

12 December 2020

10.1007/S11055-010-9347-8

Identifiers

DOI

1 reference

11 November 2017

1 reference